Table 2

 Treatment and patient outcomes. Details of 11 lung cancers diagnosed in nine patients during the surveillance study

Patient codeTime to diagnosis (months)Tumour siteHistologyHow diagnosedStageTreatmentOutcome after treatment
(C), clinical staging and (S), surgical staging; CIS, carcinoma in situ; CT, computed tomography; FB, fluorescence bronchoscopy; LLL, left lower lobe; LUL, left upper lobe; PDT, photodynamic therapy; PET, positron emission tomography; RLL, right lower lobe; RML, right middle lobe; RT, radiotherapy; RUL, right upper lobe; sq cell ca, squamous cell carcinoma; TNM, tumour-node-metastasis.
Staging is according to the international staging system.2
0013Tracheasq cell caFB: progressed from known CIS(C) T4N0M0PDTEradicated: no evidence of recurrence
11RULsq cell caFB: progressed from new CIS(C) T1N0M0Radical RTProgressive disease
00215LLLsq cell caClinical suspicion: progressed from known CIS(S) T1N0M0SurgeryAlive: no evidence of recurrent disease after 5 years
0035RMLsq cell caFB: progressed from known CIS(C) T1N0M0Radical RT (PDT unsuccessful)Progressive disease
0058RULNot knownCT surveillance followed by(C) T1N0M0Radical RTAlive: no evidence of recurrence after 3 years
PET:CT scan
00619LLLsq cell caCT surveillance, followed by(S) T1N0M0SurgeryAlive: no evidence of recurrence after 1 year
PET scan
0076RULsq cell caCT surveillance, followed by(S) T1N0M0SurgeryProgressive disease
PET scanAlive after 1 year
0094LULsq cell caFB: progressed from known CIS(C) T1N0M0PDT: refused surgery and ineligible for radical RTProgressive disease
01017LLLNot knownCT surveillance(C) T1N0M0Symptomatic: unfit for surgery/RT due to previous pneumonectomyProgressive disease
01114LL lobectomy stumpsq cell caFB: progressed from known CIS(C) T1N0M0Radical brachytherapyEradicated: no recurrence after 1 year
14RLLsq cell caCT surveillance, followed by(S) T1N0M0SurgeryNo evidence of recurrence after 1 year
PET:CT scan